Acta Med. 2017, 60: 32-36
https://doi.org/10.14712/18059694.2017.48
Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin
References
1. RC, Tenhagen M, van de Ven RA, Derksen PW. p120-catenin in cancer – mechanisms, models and opportunities for intervention. J Cell Sci 2013; 126: 3515–25.
<https://doi.org/10.1242/jcs.134411>
2. BP, Pignatelli M, Dinjens WN, Tilanus HW. Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction. J Surg Oncol 2005; 92: 116–23.
<https://doi.org/10.1002/jso.20344>
3. K, Tuikkala J, Nykänen M, et al. Altered expression of p120catenin predicts poor outcome in invasive breast cancer. Altered expression of p120catenin predicts poor outcome in invasive breast cancer. J Cancer Res Clin Oncol 2010; 136: 1377–87.
<https://doi.org/10.1007/s00432-010-0789-8>
4. B, Smith GL, Mandeville JA, et al. Prognostic significance of altered p120ctn expression in bladder cancer. BJU Int 2008; 101: 746–52.
<https://doi.org/10.1111/j.1464-410X.2007.07264.x>
5. EH, Liu Y, Xu HT, et al. Abnormal expression and clinicopathologic significance of p120-catenin in lung cancer. Histol Histopathol 2006; 21: 841–7.
6. Chen T, Wang C, Wu F, et al. Altered localization of p120 catenin in the cytoplasm rather than the membrane correlates with poor prognosis in esophageal squamous cell carcinoma. PloS One 2015; 10: e0118645. doi: 10.1371/journal.pone.0118645.
<https://doi.org/10.1371/journal.pone.0118645>
<PubMed>
7. Y, Liao L, Shrestha C, et al. Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma. Int J Clin Exp Pathol 2015; 8: 9042–51.
8. DI, Bates RC, Muzikansky A, Rimm DL, Mercurio AM. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res 2005; 65: 10938–45.
<https://doi.org/10.1158/0008-5472.CAN-05-1947>
9. IM, Tomita K, van Bokhoven A, et al. The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study. Prostate 2007; 67: 1432–8.
<https://doi.org/10.1002/pros.20626>
10. B, Yan HX, Liu SQ, et al. Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters. World J Gastroenterol 2008a; 14: 3739–44.
<https://doi.org/10.3748/wjg.14.3739>
<PubMed>
11. B, Yan HX, Liu SQ, et al. Reduced expression of E-cadherin/catenins complex in hepatocellular carcinomas. World J Gastroenterol 2008b; 14: 5665–73.
<https://doi.org/10.3748/wjg.14.5665>
<PubMed>
12. Y, Omori Y, Momiyama M, et al. Reduced expression and aberrant localization of p120catenin in human squamous cell carcinoma of the skin. J Dermatol Sci 2004; 34: 99–108.
<https://doi.org/10.1016/j.jdermsci.2003.12.001>
13. D, Tonkovic-Capin V, Hunt E, et al. Diagnostic concordance rates in the subtyping of basal cell carcinoma by different dermatopathologists. J Cutan Pathol 2014; 41: 9–13.
<https://doi.org/10.1111/cup.12256>
14. V, Kullová M. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study. Cesk Patol 2016; 52: 222–6.
15. Slater D, Walsh M. Standards and dataset for reporting cancers. Dataset for the histological reporting of primary cutaneous basal cell carcinoma. The Royal College of Pathologists. 3rd ed., May 2014. 29 pages.
16. AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod. Pathol 2006; 19(Suppl 2): S127–S147.
<https://doi.org/10.1038/modpathol.3800512>
17. V, Adamicová K, Kullová M, Péč M. Basal cell carcinoma of the skin – biological hehaviour of the tumor and a review of the most important molecular predictors of disease progression in pathological practice. Klin Onkol 2011; 24: 8–17. (in Slovak)
18. DJ, Bhargava R, Chivukula M. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol 2007; 31: 427–37.
<https://doi.org/10.1097/01.pas.0000213386.63160.3f>
19. D, Pérez-Mies B, Hardisson D, et al. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene 2004; 23: 3272–83.
<https://doi.org/10.1038/sj.onc.1207439>
20. L, Pannone G, Staibano S, et al. p120(cat) Delocalization in cell lines of oral cancer. Oral Oncol 2002; 38: 64–72.
<https://doi.org/10.1016/S1368-8375(01)00027-6>
21. J, Friess H, Büchler MW, et al. Up-regulation, nuclear import, and tumor growth stimulation of the adhesion protein p120 in pancreatic cancer. Gastroenterology 2003; 124: 949–60.
<https://doi.org/10.1053/gast.2003.50142>
22. T, Kokubu A, Sekine S, Kanai Y, Hirohashi S. Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin deficient breast cancer. Am J Pathol 2004; 164: 2269–78.
<https://doi.org/10.1016/S0002-9440(10)63783-2>
<PubMed>
